Oncopeptides CEO Sofia Heigis interviewed by Redeye about the Q2 earnings report regarding Pepaxti, commercial partnerships, and the glioblastoma program.
Oncopeptides CEO Sofia Heigis interviewed by Redeye about the Q2 earnings report regarding Pepaxti, commercial partnerships, and the glioblastoma program.
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care